CoChat

Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease

Zhou, Jun, Fonseca, Maria I., Pisalyaput, Karntipa, Tenner, Andrea J. · 2008 · Journal of Neurochemistry
Cited by 130

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disease resulting in progressive cognitive decline. Amyloid plaque deposits consisting specifically of β‐amyloid peptides that have formed fibrils displaying β‐pleated sheet conformation are associated with activated microglia and astrocytes, are colocalized with C1q and other complement activation products, and appear at the time of cognitive decline in AD. Amyloid precursor protein (APP) transgenic mouse models of AD that lack the ability to activate the classical complement pathway display less neuropathology than do the APPQ+/+ mice, consistent with the hypothesis that complement activation and the resultant inflammation may play a role in the pathogenesis of AD. Further investigation of the presence of complement proteins C3 and C4 in the brain of these mice demonstrate that both C3 and C4 deposition increase with age in APPQ+/+ transgenic mice, as expected with the age‐dependent increase in fibrillar β‐amyloid deposition. In addition, while C4 is predominantly localized on the plaques and/or associated with oligodendrocytes in APPQ+/+ mice, little C4 is detected in APPQ−/− brains consistent with a lack of classical complement pathway activation because of the absence of C1q in these mice. In contrast, plaque and cell associated C3 immunoreactivity is seen in both animal models and, surprisingly, is higher in APPQ−/− than in APPQ+/+ mice, providing evidence for alternative pathway activation. The unexpected increase in C3 levels in the APPQ−/− mice coincident with decreased neuropathology provides support for the hypothesis that complement can mediate protective events as well as detrimental events in this disease. Finally, induced expression of C3 in a subset of astrocytes suggests the existence of differential activation states of these cells.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2008.05558.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 66

  1. Anderson D. C., 1986, Contributions of the Mac‐1 glycoprotein family to adherence‐dependent granulocyte functions: structure‐function assessments employing subunit‐specific monoclonal antibodies, J. Immunol., 137, 15, 10.4049/jimmunol.137.1.15 · doi:10.4049/jimmunol.137.1.15
  2. 10.1046/j.1365-2249.1999.00835.x · DOI · Paper page
  3. 10.4049/jimmunol.138.4.1150 · DOI · Paper page
  4. 10.1016/j.molimm.2006.06.021 · DOI · Paper page
  5. 10.4049/jimmunol.173.7.4708 · DOI · Paper page
  6. 10.1016/j.neulet.2005.07.015 · DOI
  7. 10.1084/jem.188.3.431 · DOI · Paper page
  8. 10.1016/S0140-6736(89)90951-3 · doi:10.1016/s0140-6736(89)90951-3
  9. 10.1016/S0197-4580(00)00148-2 · DOI
  10. 10.1016/0197-4580(96)00117-0 · DOI
  11. 10.1006/nlme.1996.0039 · DOI · Paper page
  12. Ehtesham M., 2002, The use of interleukin 12‐secreting neural stem cells for the treatment of intracranial glioma, Cancer Res., 62, 5657
  13. 10.1186/1742-2094-2-1 · DOI
  14. 10.1186/1742-2094-4-22 · DOI · Paper page
  15. 10.4049/jimmunol.170.11.5764 · DOI · Paper page
  16. 10.1189/jlb.1105683 · DOI · Paper page
  17. 10.1074/jbc.M605741200 · DOI · Paper page
  18. 10.1111/j.1432-1033.1994.tb18802.x · doi:10.1111/j.1432-1033.1994.tb18802.x
  19. 10.1038/nm0198-097 · DOI · Paper page
  20. 10.1126/science.285.5427.595 · DOI · Paper page
  21. 10.1016/0197-4580(92)90086-D · DOI · Paper page
  22. 10.1073/pnas.192203399 · DOI · Paper page
  23. 10.1016/S0197-4580(99)00051-2 · DOI
  24. 10.1089/hyb.1990.9.309 · doi:10.1089/hyb.1990.9.309
  25. 10.1023/A:1023203122036 · DOI
  26. Levi‐Strauss M., 1987, Primary cultures of murine astrocytes produce C3 and Factor B, two components of the alternative pathway of complement activation, J. Immunol., 139, 2361, 10.4049/jimmunol.139.7.2361 · DOI · Paper page
  27. 10.1186/1742-2094-5-9 · DOI · Paper page
  28. 10.1016/j.molimm.2003.10.019 · DOI
  29. 10.1016/S0002-9440(10)64085-0 · DOI · Paper page
  30. Mitchell D. A., 1999, C1q protects against the development of glomerulonephritis independently of C3 activation, J. Immunol., 162, 5676, 10.4049/jimmunol.162.10.5676 · DOI · Paper page
  31. 10.1016/S0169-409X(02)00162-X · DOI
  32. 10.1111/j.1365-2249.2004.02646.x · DOI
  33. 10.1016/S0165-5728(99)00261-1 · DOI
  34. 10.1016/S0166-2236(98)01390-3 · DOI · Paper page
  35. 10.4049/jimmunol.173.5.3044 · DOI · Paper page
  36. Ogata R. T., 1994, Substrate specificities of murine C1s, J. Immunol., 152, 5890, 10.4049/jimmunol.152.12.5890 · doi:10.4049/jimmunol.152.12.5890
  37. 10.1002/(SICI)1097-4644(19990601)73:3<303::AID-JCB2>3.0.CO;2-2 · DOI · Paper page
  38. 10.1006/nbdi.1996.0020 · DOI
  39. 10.1111/j.1471-4159.2007.05012.x · DOI · Paper page
  40. 10.1038/sj.emboj.7601004 · DOI · Paper page
  41. 10.1016/j.neulet.2005.08.022 · DOI
  42. 10.1073/pnas.89.21.10016 · DOI · Paper page
  43. 10.1074/jbc.M206448200 · DOI · Paper page
  44. 10.1016/0306-4522(94)90473-1 · DOI · Paper page
  45. Rus H. G., 1992, Induction of C3 expression in astrocytes is regulated by cytokines and Newcastle disease virus, J. Immunol., 148, 928, 10.4049/jimmunol.148.3.928 · DOI
  46. 10.1080/07853890510007278 · DOI · Paper page
  47. 10.1016/j.jneuroim.2006.07.009 · DOI
  48. 10.1146/annurev.pharmtox.43.100901.140248 · DOI · Paper page
  49. 10.1016/j.jneuroim.2004.06.003 · DOI
  50. 10.1016/S0006-8993(97)00850-0 · DOI · Paper page
  51. 10.1007/s004010100447 · DOI
  52. 10.1016/S0169-328X(00)00149-2 · DOI
  53. 10.1007/978-0-387-73894-9_8 · DOI
  54. 10.1093/intimm/12.7.1015 · DOI · Paper page
  55. 10.1097/00001756-200102120-00022 · DOI · Paper page
  56. 10.1111/j.1749-6632.2003.tb03138.x · DOI · Paper page
  57. 10.1006/exnr.1999.7199 · DOI
  58. 10.1007/BF01600164 · DOI
  59. 10.1016/0169-328X(92)90017-6 · DOI · Paper page
  60. 10.3109/13506129709014379 · DOI · Paper page
  61. 10.1016/S0197-4580(97)00042-0 · DOI · Paper page
  62. 10.1096/fj.05-5814com · DOI · Paper page
  63. 10.1002/eji.200324026 · DOI · Paper page
  64. Yang L. B., 2000, Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer’s disease, J. Neurosci., 20, 7505, 10.1523/JNEUROSCI.20-20-07505.2000 · DOI · Paper page
  65. 10.1186/1742-2094-1-21 · DOI
  66. 10.1186/1742-2094-2-28 · DOI · Paper page

Cited by

See all 130

Metadata

Authors
Zhou, J., Fonseca, M. I., Pisalyaput, K., & Tenner, A. J.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2008-08-11
Volume
106
Issue
5
Pages
2080-2092
ISSN
  • 0022-3042
  • 1471-4159
Cited by
130
References
15
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease. https://app.cochat.ai/papers/10.1111/j.1471-4159.2008.05558.x
The paper
Zhou, J., Fonseca, M. I., Pisalyaput, K., & Tenner, A. J. (2008). Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer’s disease. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2008.05558.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.